ALG6 alpha-1,3-glucosyltransferase
Senast uppdaterad 5 Jul 2022
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Den ALG6 gene provides instructions for making an enzyme that is involved in a process called glycosylation. Glycosylation is a process by which sugar molecules (oligosaccharides) are attached to proteins and fats. Oligosaccharides are made up of many sugar molecules that are attached to one another in a stepwise process forming a complex chain. Glycosylation modifies proteins so they can perform a wider variety of functions. The enzyme produced from the ALG6 gene transfers a simple sugar called glucose to the growing oligosaccharide. Once the correct number of sugar molecules are linked together, the oligosaccharide is attached to a protein or fat.
Videoval för GenesVideobibliotek
Normal function
Den ALG6 gene provides instructions for making an enzyme that is involved in a process called glycosylation. Glycosylation is a process by which sugar molecules (oligosaccharides) are attached to proteins and fats. Oligosaccharides are made up of many sugar molecules that are attached to one another in a stepwise process forming a complex chain. Glycosylation modifies proteins so they can perform a wider variety of functions. The enzyme produced from the ALG6 gene transfers a simple sugar called glucose to the growing oligosaccharide. Once the correct number of sugar molecules are linked together, the oligosaccharide is attached to a protein or fat.
Conditions referring to this gene or chromosome
Other names
asparagine-linked glycosylation 6 homolog (S. cerevisiae, alpha-1,3-glucosyltransferase)
asparagine-linked glycosylation 6 homolog (yeast, alpha-1,3-glucosyltransferase)
asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog
asparagine-linked glycosylation protein 6 homolog
dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase
dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase
dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase precursor
dolichyl-P-Glc:Man(9)GlcNAc(2)-PP-dolichol alpha- 1->3-glucosyltransferase
dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase
dolichyl-P-Glc:Man9GlcNAc2-PP-dolichylglucosyltransferase
Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase
Related patient information and medicines

Patient information leaflet
Leverfunktionstester
Changes in liver function tests give a clue as to whether your levern is under strain, infl... Liver function Liver function The liver is a factory for the production and breakdown of carbohydrates, fats, proteins, hormones and other essential body chemicals, and helps dispose of waste products. En isolated rise in un. What does an abnormal.

Patient information leaflet
Leversvikt
This is called chronic liver disease. See the separate leaflet called Cirrhosis for further information. Liver failure can also develop rapidly over just a few days (acute liver failure). How common is liver failure. Acute liver failure is very uncommon: In England , there were 688 liver transplants, 28 in Scotland, 69 in Wales and 24 in Northern.

Patient information leaflet
Kronisk prostatit
For chronic prostatitis/CPPS , possible treatments may include the following: Antibiotics - these may be ... It may be that some antibiotics have anti-inflammatory properties as well or that they may clear some germs (bacteria) that are difficult to find when your urine is tested. Alpha-blockers Alpha-blockers - are medicines that are used to.

Patient information leaflet
Screening för Downs syndrom
The rest of this leaflet concentrates on screening for Downs syndrom och the diagnosis of Down's syndrome during pregnancy, before the baby is born. What is the difference ... What Down's syndrome screening tests are available? 10-14 weeks - combined test The standard test for Down's syndrome includes a combination of a nuchal translucency scan.

Patient information leaflet
Högt blodtryck
Healthcare professionals sometimes call high blood pressure 'hypertension'. [/health/high-blood-pressure-hypertension](https://patient.info/health/high-blood-pressure-hypertension) Understanding a blood pressure reading Blood pressure readings are given as two numbers, eg 130/80. A blood test to ... A heart tracing, called an.

Patient information leaflet
Kan jag ta Karbocistein och Omega-3 tillsammans?
Omega-3 fatty acids are nutrients used by the body for various functions, including heart and brain health. Using othe... Our Interaktionskontroll för läkemedel helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Simply search for your medicines to see potential interactions and what to do.
Vidare läsning och referenser
- ALG6 alpha-1,3-glucosyltransferase; MedlinePlus, National Library of Medicine.
- Grunewald S, Imbach T, Huijben K, Rubio-Gozalbo ME, Verrips A, de Klerk JB, Stroink H, de Rijk-van Andel JF, Van Hove JL, Wendel U, Matthijs G, Hennet T, Jaeken J, Wevers RA. Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis. Ann Neurol. 2000 Jun;47(6):776-81.
- Imbach T, Burda P, Kuhnert P, Wevers RA, Aebi M, Berger EG, Hennet T. A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic. Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6982-7. doi: 10.1073/pnas.96.12.6982.
- Sparks SE, Krasnewich DM. Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. 2005 Aug 15 [updated 2017 Jan 12]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1332/
- Westphal V, Xiao M, Kwok PY, Freeze HH. Identification of a frequent variant in ALG6, the cause of Congenital Disorder of Glycosylation-Ic. Hum Mutat. 2003 Nov;22(5):420-1. doi: 10.1002/humu.9195.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
5 Jul 2022 | Senaste versionen
1 May 2014 | Ursprungligen publicerad
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

